Teva Pharmaceutical Industries Limited logo
Teva Pharmaceutical Industries Limited TEVA
$ 21.92 2.86%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Teva Pharmaceutical Industries Limited Financial Ratios 2011-2024 | TEVA

Annual Financial Ratios Teva Pharmaceutical Industries Limited

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-26.0 -8.8 22.3 -3.2 -11.2 -9.5 -1.3 96.9 31.1 14.6 27.3 14.4 12.3

P/S

0.9 0.8 0.6 0.8 0.7 1.1 0.9 1.5 2.5 2.2 1.7 1.4 1.8

EPS

-0.5 -1.2 0.4 -3.6 -0.9 -2.4 -16.3 0.1 1.8 3.6 1.5 2.2 3.1

EV (Enterprise Value)

46.6 B 44 B 43.5 B 50.3 B 52.7 B 64.6 B 71.9 B 88.8 B 66.8 B 65.4 B 58.5 B 53.1 B 60.5 B

EBITDA per Share

1.42 0.33 2.76 -1.84 1.17 0.201 6.01 6.47 7.51 7.03 6.6 6.75 5.71

EV/EBITDA

14.1 7.9 9.4 232.0 8.0 10.3 7.9 8.5 7.9 6.3 8.5

PEG

-0.59 0.21 -0.88 -0.15 -0.2 -0.11 0.0 -1.01 -0.64 0.1 -0.81 -0.52 -0.74

P/B

1.8 1.3 0.8 1.2 0.8 1.4 1.1 0.9 1.7 1.9 1.5 1.2 1.5

P/CF

10.6 7.2 11.6 10.6 50.2 11.4 8.0 7.4 10.4 10.6 15.7 8.1 11.0

ROE %

-7.45 -16.67 3.71 -36.07 -7.15 -14.62 -86.77 0.94 5.31 13.08 5.61 8.58 12.35

ROA %

-1.29 -2.96 0.87 -7.88 -1.74 -3.54 -23.03 0.35 2.93 6.58 2.67 3.88 5.50

ROCE %

1.41 -2.96 4.68 -9.53 -1.01 -3.53 7.57 6.26 12.40 13.16 11.14 11.08 11.05

Current Ratio

1.2 1.2 1.3 1.3 1.0 1.0 0.9 0.9 1.4 1.2 1.1 1.3 1.0

DSO

81.8 100.6 104.7 112.4 122.7 112.7 116.2 125.4 99.4 97.4 95.9 100.1 123.8

DIO

174.8 175.6 181.1 180.3 172.6 163.6 155.5 180.0 174.5 173.1 192.0 207.8 208.0

DPO

99.9 82.0 75.8 35.9 67.1 64.1 65.3 78.4 - - - - -

Operating Cycle

256.6 276.2 285.8 292.7 295.3 276.3 271.7 305.4 273.9 270.5 287.9 307.9 331.8

Cash Conversion Cycle

156.7 194.2 210.0 256.8 228.2 212.2 206.4 227.0 273.9 270.5 287.9 307.9 331.8

All numbers in USD currency

Quarterly Financial Ratios Teva Pharmaceutical Industries Limited

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.39 -0.75 -0.12 0.06 -0.78 -0.2 - 0.05 -0.21 -0.86 - 0.26 0.19 0.07 0.14 -3.97 0.13 0.06 0.1 -0.29 -0.63 -0.1 -2.85 -0.27 -0.24 1.04 -11.41 0.52 -5.94 0.57 -1.02 0.35 0.21 0.62 - 0.12 0.64 0.52 - 1.02 0.88 0.88 - 0.84 -0.53 0.74 - -0.09 0.99 0.98 - 1.03 0.65 0.85

EBITDA per Share

0.18 0.22 0.05 0.56 -0.32 0.26 - 0.67 -0.53 -0.35 - 1.48 0.68 0.74 - -2.9 0.87 0.54 - 1.12 0.23 0.53 - 1.45 0.95 2 - 1.93 -4.6 1.35 - 0.78 0.39 1.61 - 1.19 0.78 1.27 - 1.3 1.09 1.62 - 0.95 -0.69 1.47 - -0.07 1.16 1.64 - 1.17 0.67 1.26

ROE %

-21.49 -25.77 -15.05 -12.55 -12.90 -3.77 -11.08 -8.53 -6.57 -2.20 5.33 6.82 -39.11 -39.71 -39.80 -40.51 0.62 -5.70 -7.14 -27.55 -26.72 -22.99 -14.62 -61.45 -56.60 -89.80 -93.70 -26.08 -28.33 6.90 4.10 4.56 3.84 5.34 4.76 8.47 11.72 12.56 10.12 13.31 12.79 7.51 3.86 3.52 -0.02 5.88 7.18 11.18 15.53 14.17 9.74 4.01 2.43 3.30

ROA %

-3.25 -4.23 -2.69 -2.24 -2.28 -2.28 -3.93 -3.32 -0.81 -0.39 1.19 1.48 -7.71 -7.86 -7.88 -7.98 0.06 -1.42 -1.74 -6.68 -6.48 -5.57 -3.54 -15.12 -13.94 -22.10 -23.03 -6.28 -6.71 2.19 2.01 2.22 2.02 2.65 2.23 4.11 5.78 6.31 5.07 6.55 6.16 3.61 1.84 1.69 0.04 2.76 3.31 5.53 7.91 7.57 5.59 2.22 1.43 1.94

ROCE %

0.16 -1.75 -1.77 0.27 0.43 -7.13 -10.39 -8.66 -8.21 3.09 4.58 -7.34 -20.98 -22.15 -10.92 -11.11 0.62 -1.36 -1.38 -1.35 -1.12 0.35 3.37 4.11 4.81 -6.35 -8.71 -7.72 -7.47 4.58 4.62 7.47 9.33 10.31 6.87 10.05 10.39 11.20 8.59 10.83 9.90 5.55 3.01 2.85 0.45 4.74 4.97 8.46 12.09 11.48 8.33 3.48 1.99 2.86

Current Ratio

1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.3 - 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.6 1.6 2.2 2.2 2.2 1.9 1.9 1.9 2.0 2.0 2.0 2.0 1.9 1.9 1.8 1.9 1.8 1.9 1.9 1.9 1.8 2.2 2.5 2.4

DSO

76.1 79.1 81.7 82.0 82.0 88.9 - 47.3 51.2 109.5 - 100.2 105.7 104.9 93.8 105.1 108.0 107.4 115.9 126.5 124.0 126.4 120.2 121.2 116.7 116.7 119.2 115.9 113.7 118.3 109.6 110.3 95.7 100.0 - 102.6 101.8 100.0 - 97.4 96.4 96.8 - 94.7 99.3 102.3 - 102.9 104.9 112.1 - 116.3 119.6 -

DIO

164.8 167.9 178.2 186.2 180.3 174.5 - 91.4 91.9 186.0 - 185.9 196.4 191.0 - 189.0 190.7 175.5 - 178.2 176.7 182.1 - 169.2 161.8 160.2 - 151.4 156.8 160.3 - 153.1 166.4 179.2 - 184.9 185.7 181.7 - 193.3 189.8 198.6 - 198.5 209.7 214.9 - 206.9 207.4 189.3 - 198.5 196.9 -

DPO

99.0 102.4 105.1 109.3 107.1 93.7 - 38.7 40.1 81.6 - 66.8 72.6 74.8 - 75.4 76.0 69.1 - 69.2 68.6 34.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

240.9 247.1 259.9 268.3 262.3 263.4 - 138.8 143.1 295.4 - 286.1 302.1 295.9 93.8 294.1 298.7 282.9 115.9 304.8 300.7 308.6 120.2 290.3 278.5 276.8 119.2 267.4 270.5 278.6 109.6 263.4 262.1 279.1 - 287.5 287.4 281.6 - 290.8 286.2 295.4 - 293.2 309.0 317.2 - 309.8 312.4 301.4 - 314.8 316.5 -

Cash Conversion Cycle

141.9 144.6 154.8 159.0 155.2 169.7 - 100.0 103.1 213.8 - 219.3 229.5 221.1 93.8 218.7 222.7 213.8 115.9 235.5 232.0 274.4 120.2 290.3 278.5 276.8 119.2 267.4 270.5 278.6 109.6 263.4 262.1 279.1 - 287.5 287.4 281.6 - 290.8 286.2 295.4 - 293.2 309.0 317.2 - 309.8 312.4 301.4 - 314.8 316.5 -

All numbers in USD currency